22 results on '"Beauvieux, Marie-Christine"'
Search Results
2. Monitoring of heparinization in cardiac surgery with ACT: accreditation of the point-of-care test in the Bordeaux University Hospital Centre
- Author
-
Landrieu, Valentin, additional, Beauvieux, Marie Christine, additional, Vidal, Thomas, additional, Mouton, Christine, additional, Castaing-Mouhica, Gladys, additional, Dusseau, Laurent, additional, Stanciu, Eugen, additional, Domingorena, Julien, additional, Roux, David, additional, Catel, Julien, additional, Moreno, Valerie, additional, Berthon, Nathalie, additional, Bachellerie, Delphine, additional, Poisvert, Sandy, additional, and Delassasseigne, Céline, additional
- Published
- 2023
- Full Text
- View/download PDF
3. Place of biomarkers in the renutrition of patients with serious Covid-19 infection: discussion around a clinical case
- Author
-
Schnebelen, Marie, additional, Petit, Laurent, additional, Rigalleau, Vincent, additional, Lacape, Geneviève, additional, Beauvieux, Marie-Christine, additional, and Gatta-Cherifi, Blandine, additional
- Published
- 2022
- Full Text
- View/download PDF
4. POCT-management during the first wave of Covid-19 in France. Results of a national survey leaded by the SFBC-POCT Working Group
- Author
-
Glady, Ludovic, additional, Moal, Valérie, additional, Benz-De Bretagne, Isabelle, additional, Bouvier, Damien, additional, Di Giovanni, Flore, additional, Chenevier-Gobeaux, Camille, additional, Jeannesson, Elise, additional, Jolly, Emilie, additional, Kadi, Habiba, additional, Oueidat, Nathalie, additional, Pernet, Pascal, additional, Pieroni, Laurence, additional, Poupon, Carole, additional, Toussaint-Hacquard, Marie, additional, Dubos, Mickaël, additional, Martinel, Isabelle, additional, Chauzit, Emmanuelle, additional, and Beauvieux, Marie-Christine, additional
- Published
- 2021
- Full Text
- View/download PDF
5. Biomarkers in diabetes mellitus: contributions and discrepancies of new technologies. A case report
- Author
-
Mialon, Florian, additional, Catargi, Bogdan, additional, Rami, Lila, additional, Barat, Pascal, additional, Bedel, Aurélie, additional, Lacape, Geneviève, additional, Bérard, Annie M., additional, and Beauvieux, Marie-Christine, additional
- Published
- 2021
- Full Text
- View/download PDF
6. Proteinuria typing: how, why and for whom?
- Author
-
Pallet, Nicolas, Bastard, Jean-Philippe, Claeyssens, Sophie, Fellahi, Soraya, Delanaye, Pierre, Piéroni, Laurence, Caussé, Elizabeth, Beauvieux, Marie-Christine, Benz-de Bretagne, Isabelle, Bigot-Corbel, Edith, Boutten, Anne, Carlier, Marie-Christine, Cavalier, Étienne, Cristol, Jean-Paul, Delatour, Vincent, Fila, Marc, Mariat, Christophe, Perrier, Franck, Plouvier, Elisabeth, Roger, Christelle, Séronie-Vivien, Sophie, Hôpital Européen Georges Pompidou [APHP] (HEGP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO), CHU Tenon [AP-HP], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Laboratoire de biochimie générale [Rouen], CHU Rouen, Normandie Université (NU)-Normandie Université (NU)-Université de Rouen Normandie (UNIROUEN), Normandie Université (NU)-Centre hospitalier universitaire de Rouen, Hôpital Charles Nicolle [Rouen], Normandie Université (NU), Centre Hospitalier Universitaire de Liège (CHU-Liège), Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Laboratoire de Biochimie [Purpan], Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-CHU Toulouse [Toulouse]-Institut Fédératif de Biologie (IFB) - Hôpital Purpan, Hôpital Purpan [Toulouse], CHU Toulouse [Toulouse]-CHU Toulouse [Toulouse]-Hôpital Purpan [Toulouse], CHU Toulouse [Toulouse], Physiologie & médecine expérimentale du Cœur et des Muscles [U 1046] (PhyMedExp), Université de Montpellier (UM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS), Laboratoire National de Métrologie et d'Essais [Trappes] (LNE ), and Centre Hospitalier Universitaire de Saint-Etienne (CHU de Saint-Etienne)
- Subjects
kidney disease ,[SDV]Life Sciences [q-bio] ,Urinalysis ,030204 cardiovascular system & hematology ,Kidney Function Tests ,urologic and male genital diseases ,Diagnostic tools ,Bioinformatics ,Diagnosis, Differential ,03 medical and health sciences ,0302 clinical medicine ,medicine ,Humans ,Typing ,Kidney ,Proteinuria ,urogenital system ,business.industry ,Patient Selection ,monoclonal gammopathy ,General Medicine ,medicine.disease ,female genital diseases and pregnancy complications ,Monoclonal component ,medicine.anatomical_structure ,030220 oncology & carcinogenesis ,Etiology ,Kidney Diseases ,urinary protein profiling ,Typing methods ,proteinuria ,medicine.symptom ,business ,Glomerular Filtration Rate ,urinary electrophoresis ,Kidney disease - Abstract
International audience; The typing of proteinuria is one of the complementary examinations carried out during the exploration of proteinuria. It aims to separate and identify the different proteins, or fractions of proteins, that make up proteinuria. The nature and relative importance of the proteins present reflect the location of the renal involvement and help to determine the etiology. The typing of a proteinuria also allows the detection of a monoclonal component in urine and its quantification. Finally, it allows highlighting the existence of a proteinuria of overload that can occur in the absence of kidney damage. Many methods allow the typing of proteinuria, and these have benefited in recent years from technological advances. The purpose of this review is to summarize typing methods currently used, their benefits and limitations, and the help that these diagnostic tools can provide to the management of patients.; Le typage des protéinuries constitue un des examens complémentaires mis en œuvre au cours de l’exploration d’une protéinurie. Il vise à séparer et à identifier les différentes protéines, ou fractions de protéines, qui composent la protéinurie. La nature et l’importance relative des protéines présentes reflètent la localisation de l’atteinte rénale et contribuent à en déterminer l’étiologie. Le typage d’une protéinurie permet également la détection d’un composant monoclonal urinaire ainsi que sa quantification. Enfin, elle permet de mettre en évidence l’existence d’une protéinurie de surcharge autre que les chaînes légères libres d’immunoglobulines pouvant survenir en l’absence de lésion rénale. De nombreuses méthodes permettent le typage des protéinuries, et celles-ci ont bénéficié ces dernières années d’avancées technologiques. L’objet de cette revue est de faire la synthèse des méthodes de typage actuellement utilisées, de leurs avantages et de leurs limites, et de l’aide que ces analyses peuvent apporter à la prise en charge des malades.
- Published
- 2019
- Full Text
- View/download PDF
7. Atteintes myocardiques au cours de la maladie à coronavirus 19 (Covid-19) : principaux mécanismes physiopathologiques et utilité clinique des biomarqueurs cardiaques
- Author
-
Kamel, Saïd, Raynor, Alexandre, Zozor, Samuel, Lacape, Geneviève, Brunel, Valéry, NIVET-ANTOINE, Valérie, Collin-Chavagnac, Delphine, Peoc’h, Katell, Cohen, Ariel, Lassoued, Amin Ben, Chévrier, Marc, Alemann, Mathieu, Lessinger, Jean-Marc, Bérard, Annie, Sapin, Vincent, Beauvieux, Marie-Christine, Levy, Pacifique, Peoc, Katell, Lassoued, Amin, Centre de résonance magnétique des systèmes biologiques (CRMSB), and Centre National de la Recherche Scientifique (CNRS)-Université de Bordeaux (UB)
- Subjects
myocardite ,peptides natriurétiques ,SARS-CoV-2 ,[SDV]Life Sciences [q-bio] ,myocarde ,troponine ,Covid-19 - Abstract
International audience; Pour citer cet article : Atteintes myocardiques au cours de la maladie à coronavirus 19 (Covid-19) : principaux mécanismes physiopathologiques et utilité clinique des biomarqueurs cardiaques.
- Published
- 2021
- Full Text
- View/download PDF
8. Myocardial injury in coronavirus disease 19 (Covid-19): main pathophysiological mechanisms and clinical utility of cardiac biomarkers
- Author
-
Kamel, Said, additional, Raynor, Alexandre, additional, Zozor, Samuel, additional, Lacape, Geneviève, additional, Brunel, Valéry, additional, Nivet-Antoine, Valérie, additional, Collin-Chavagnac, Delphine, additional, Peoc’h, Katell, additional, Cohen, Ariel, additional, Lassoued, Amin Ben, additional, Chévrier, Marc, additional, Alemann, Mathieu, additional, Lessinger, Jean-Marc, additional, Bérard, Annie M., additional, Sapin, Vincent, additional, Beauvieux, Marie-Christine, additional, and Levy, Pacifique, additional
- Published
- 2021
- Full Text
- View/download PDF
9. How to accredit bedside total hemoglobin measurement with the HemoCue® point-of-care device?
- Author
-
Augis, Vanessa, additional, Weinmann, Laurent, additional, Castaing-Mouhica, Gladys, additional, Terral, Catherine, additional, Berthon, Nathalie, additional, Pujol, Sophie, additional, and Beauvieux, Marie-Christine, additional
- Published
- 2021
- Full Text
- View/download PDF
10. Gestion d'une crise sanitaire mondiale: Premiers retours d'expérience de biologistes médicaux d'Outre-mer et de francophonie face au COVID-19
- Author
-
UCL - SSS/IREC/EDIN - Pôle d'endocrinologie, diabète et nutrition, UCL - (SLuc) Service de biochimie médicale, Barguil, Yann, Chiaradia, Laura, Sicard, Didier, Duhin, Madeline, Sebat, Cathy, Abdi, Samia, Alomar, Yves, Blondeel, Nicolas, Bonnet, Christophe, Bouberi-Niava, Bénita, Bourgoin-Rousset, Emmanuelle, Cavalier, Etienne, Cisse, Fatou, Combe, Patrice, de Guire, Vincent, Devaud, François, De Wulf, Annelies, Agne, Fatou Diallo, Dumas-Chastang, Elsa, Ecrabey, Yann Christian, Grignon, Jean-Claude, Gruson, Damien, Gueye, Papa Madieye, Hayette, Marie-Pierre, Kabré, Eli, Kandji, Pape Matar, Kouakou, Henri Francisk, Legris-Allusson, Véronique, Lim, Stephen, Monde, Absalome, Monnet, Dagui, Forton, Guillaume Nguyen, Outreville, Jonathan, Padelli, Maël, Sakandé, Jean, Sall, Abibatou, Subiros, Marion, Tayeb, Nicole, Temmar, Abdelhakim, Thiam, Souleymane, Ting Wang, Han, Bérard, Annie M, Piéroni, Laurence, Sapin, Vincent, Beauvieux, Marie-Christine, Membres du groupe de travail « SFBC Marqueurs biochimiques COVID-19 », UCL - SSS/IREC/EDIN - Pôle d'endocrinologie, diabète et nutrition, UCL - (SLuc) Service de biochimie médicale, Barguil, Yann, Chiaradia, Laura, Sicard, Didier, Duhin, Madeline, Sebat, Cathy, Abdi, Samia, Alomar, Yves, Blondeel, Nicolas, Bonnet, Christophe, Bouberi-Niava, Bénita, Bourgoin-Rousset, Emmanuelle, Cavalier, Etienne, Cisse, Fatou, Combe, Patrice, de Guire, Vincent, Devaud, François, De Wulf, Annelies, Agne, Fatou Diallo, Dumas-Chastang, Elsa, Ecrabey, Yann Christian, Grignon, Jean-Claude, Gruson, Damien, Gueye, Papa Madieye, Hayette, Marie-Pierre, Kabré, Eli, Kandji, Pape Matar, Kouakou, Henri Francisk, Legris-Allusson, Véronique, Lim, Stephen, Monde, Absalome, Monnet, Dagui, Forton, Guillaume Nguyen, Outreville, Jonathan, Padelli, Maël, Sakandé, Jean, Sall, Abibatou, Subiros, Marion, Tayeb, Nicole, Temmar, Abdelhakim, Thiam, Souleymane, Ting Wang, Han, Bérard, Annie M, Piéroni, Laurence, Sapin, Vincent, Beauvieux, Marie-Christine, and Membres du groupe de travail « SFBC Marqueurs biochimiques COVID-19 »
- Abstract
La Société française de biologie clinique « Marqueurs biochimiques de COVID-19 » a constitué un groupe de travail ayant pour but premier de faire le point, d’analyser, de suivre l’évolution des prescriptions biologiques en fonction du parcours de soins du patient et de rechercher des marqueurs d’évolutivité et de gravité de la maladie. Cette étude recouvre tous les secteurs publics et privés de la biologie médicale situés en France métropolitaine et ultra-marine et s’étend également à la francophonie. Dans cet article, sont présentés les témoignages et données obtenus pour le sous-groupe de travail « Outre-mer et francophonie » composé de 45 correspondants volontaires, répartis dans 20 régions du monde. Au vu d’une propagation décalée du virus SARS-CoV-2, les régions d’Outre-mer et les régions francophones ont bénéficié des retours d’expériences des premiers territoires confrontés au COVID-19. Ainsi, l’entrée du virus ou sa propagation sous forme épidémique ont pu être évitées grâce à la fermeture rapide des frontières. Les territoires ultramarins dépendent très fortement des liaisons aériennes et/ou maritimes avec la métropole ou avec le continent voisin. L’isolement de ces pays est responsable de difficultés d’approvisionnement en réactifs et a nécessité des commandes en urgence et la mise en place de stocks de plusieurs mois, afin d’éviter les pénuries et de maintenir une prise en charge adéquate des patients. De plus, dans les pays situés en zones tropicales ou intertropicales, le diagnostic de COVID-19 est compliqué par la présence de diverses zoonoses (dengue, Zika, paludisme, leptospirose, etc.)., [Management of a global health crisis: first COVID-19 disease feedback from Overseas and French-speaking countries medical biologists]. The French society of clinical biology "Biochemical markers of COVID-19" has set up a working group with the primary aim of reviewing, analyzing and monitoring the evolution of biological prescriptions according to the patient's care path and to look for markers of progression and severity of the disease. This study covers all public and private sectors of medical biology located in metropolitan and overseas France and also extends to the French-speaking world. This article presents the testimonies and data obtained for the "Overseas and French-speaking countries" sub-working group made up of 45 volunteer correspondents, located in 20 regions of the world. In view of the delayed spread of the SARS-CoV-2 virus, the overseas regions and the French-speaking regions have benefited from feedback from the first territories confronted with COVID-19. Thus, the entry of the virus or its spread in epidemic form could be avoided, thanks to the rapid closure of borders. The overseas territories depend very strongly on air and/or sea links with the metropolis or with the neighboring continent. The isolation of these countries is responsible for reagent supply difficulties and has necessitated emergency orders and the establishment of stocks lasting several months, in order to avoid shortages and maintain adequate patient care. In addition, in countries located in tropical or intertropical zones, the diagnosis of COVID-19 is complicated by the presence of various zoonoses (dengue, Zika, malaria, leptospirosis, etc.).
- Published
- 2020
11. Abstracts from the French-Speaking Days of Medical Biology
- Author
-
de Maeseneer, Jan, additional, Beauvieux, Marie-Christine, additional, Pamoukdjian, Frédéric, additional, and Souberbielle, Jean-Claude, additional
- Published
- 2021
- Full Text
- View/download PDF
12. SARS-CoV-2 and neurological disorders: the revelance of biomarkers?
- Author
-
Bigot-Corbel, Edith, additional, Lanore, Aymeric, additional, Raulet, Celia, additional, Delorme, Cécile, additional, Azulay, Jean-Philippe, additional, Lehmann, Sylvain, additional, Beaudeux, Jean-Louis, additional, Beauvieux, Marie-Christine, additional, Sapin, Vincent, additional, Peoc’h, Katell, additional, and Rucheton, Benoit, additional
- Published
- 2021
- Full Text
- View/download PDF
13. How did the private labs fit onto COVID-19 crisis?
- Author
-
Galhaud, Jean-Philippe, additional, Scherrer, Florian, additional, Kemeny, Stephan, additional, Beauvieux, Marie-Christine, additional, and Delevallee, Céline, additional
- Published
- 2020
- Full Text
- View/download PDF
14. Point-of-care testing: place of France in the world National survey in healthcare establisments in 2019
- Author
-
Beauvieux, Marie-Christine, additional, Bost, Erika, additional, Castaing-Mouhica, Gladys, additional, Terral, Catherine, additional, Berthon, Nathalie, additional, Martinel, Isabelle, additional, and Chauzit, Emmanuelle, additional
- Published
- 2020
- Full Text
- View/download PDF
15. SFBC working group “Biochemical markers of COVID-19”
- Author
-
Beauvieux, Marie-Christine, additional, Bérard, Annie M., additional, Aimone-Gastin, Isabelle, additional, Barbé, Françoise, additional, Barguil, Yann, additional, Collin-Chavagnac, Delphine, additional, Delacour, Hervé, additional, Delevallée, Céline, additional, Nivet-Antoine, Valérie, additional, Peoc’h, Katell, additional, Poupon, Carole, additional, Schmitt, François, additional, Piéroni, Laurence, additional, and Sapin, Vincent, additional
- Published
- 2020
- Full Text
- View/download PDF
16. Interest of albuminuria in nephrology, diabetology and as a marker of cardiovascular risk
- Author
-
Souweine, Jean-Sébastien, additional, Corbel, Alice, additional, Rigothier, Claire, additional, Roque, Charlotte Dumas de La, additional, Hadjadj, Samy, additional, Cristol, Jean-Paul, additional, Combe, Christian, additional, Bigot-Corbel, Edith, additional, and Beauvieux, Marie-Christine, additional
- Published
- 2019
- Full Text
- View/download PDF
17. Determination of serum albumin, analytical challenges: a French multicenter study
- Author
-
Rossary, Adrien, additional, Blondé-Cynober, Françoise, additional, Bastard, Jean-Philippe, additional, Beauvieux, Marie-Christine, additional, Beyne, Pascale, additional, Drai, Jocelyne, additional, Lombard, Christine, additional, Anglard, Ingrid, additional, Aussel, Christian, additional, Claeyssens, Sophie, additional, and Vasson, Marie-Paule, additional
- Published
- 2017
- Full Text
- View/download PDF
18. [Use of HemoCue® or portable hemoglobinometer: results of the national surveys carried out by the SFBC POCT working group].
- Author
-
Tassin T, Glady L, Moal V, Oueidat N, Martinel I, Dubos M, Bretagne IB, Weinmann L, and Beauvieux MC
- Subjects
- Humans, Hemoglobins analysis, Anemia diagnosis, Anemia blood, Surveys and Questionnaires, Point-of-Care Systems standards, France epidemiology, Point-of-Care Testing standards, Health Care Surveys standards, Procedures and Techniques Utilization standards, Procedures and Techniques Utilization statistics & numerical data, Hemoglobinometry standards, Hemoglobinometry instrumentation, Hemoglobinometry methods
- Abstract
Hemoglobin (Hb) measurement is a fundamental biological test, especially in emergency situations where rapid medical decisions are required. Portable hemoglobinometers, such as HemoCue®, provide a delocalized solution for capillary whole blood. The SFBC's POCT News and Issues working group designed and conducted two national surveys to assess the use and management of these devices, both on the clinical and biological side, with 306 and 160 responses respectively. The surveys revealed little effective or desired network connection, heterogeneity in management and training, and only 7% of sites fully accredited, although a quality approach is being structured in 45% of cases. Nearly 80% of biologists suggest reclassification as a rapid diagnostic test, citing difficult standards management and inadequate human resources. However, its daily use goes beyond the simple diagnostic orientation of anemia; blood transfusion decisions without laboratory verification are made by 53% of physicians, while 18% of users are unaware of minimum maintenance procedures, underscoring the need for a rigorous quality approach. The SFBC working group proposes a list of tips to help medical biologists implement this approach, a guarantee of reliable results, in the context of medical decision-making. The selected points are fleet mapping, relations with biomedical and clinical departments, quality documents and minimum method verification, user management, QC management and traceability of results.
- Published
- 2024
- Full Text
- View/download PDF
19. Review of nutritional components in Covid-19: what about micronutrients?
- Author
-
Bost M, Richard E, Redonnet-Vernhet I, Parant F, Boulet L, Dupré T, Collin-Chavagnac D, Mesli S, and Beauvieux MC
- Subjects
- Humans, Micronutrients, Nutritional Status, Vitamin A, Vitamins therapeutic use, COVID-19 epidemiology, Trace Elements therapeutic use
- Abstract
Nutritional status is an important protection factor against viral infections. Both undernutrition and malnutrition cause deficits in micronutrients, trace elements and vitamins necessary for various physiological functions and the appropriate functioning of the immune system. These deficiencies and infectious diseases often coexist, with complex interactions. An assessment of the micro-nutrient nutritional status of Covid-19 patients has not been at the center of priorities and recommendations, due to both the medical emergency and the absence of direct evidence and rapid effects of supplementation. Few recommendations have come from learned societies due to the lack of significant evidence of the effects of supplementation in positive patients and a need for robust studies. Essential trace elements and vitamins are necessary for the differentiation, activation and execution of many functions of immune cells, but their specific role has yet to be defined. This review article discusses in the context of Covid-19 the importance of micronutrients (selenium, copper, zinc, vitamins C, D, A and those of group B) in the host to tend towards an optimization of the immune response to infections. A nutritional balance remains the key word for achieving micronutrient homeostasis. Attention had to be paid to micronutrients in primary prevention, in the general population, in order to reduce the risk of impaired nutritional status in case of major health situations.
- Published
- 2022
- Full Text
- View/download PDF
20. Two-year clinico-biological feedback in Overseas France and French-speaking territories during Covid-19 pandemic
- Author
-
Barguil Y, Busca S, Moury PH, Lamorinière M, Raz M, Chavant A, Duhin M, Chiaradia L, Couadou E, Bérard AM, Sapin V, and Beauvieux MC
- Subjects
- Animals, Feedback, Humans, Pandemics, Zoonoses, COVID-19 epidemiology, Kidney Failure, Chronic, Zika Virus, Zika Virus Infection
- Abstract
The French Society of Clinical Biology (SFBC) set up a working group “Biochemical markers of Covid-19” whose main objective is to review, analyse and monitor biological prescriptions according to the patient’s care path. This study covers all public and private sectors of medical biology in metropolitan France and overseas and extends to the French-speaking world. We present a summary of feedbacks after 2 years of the pandemic. At the early stage of Covid-19, with regard to the regions surveyed, a common symptomatology with local zoonosis (dengue fever, zika, malaria, leptospirosis, etc.) complicates the diagnosis of Covid-19. At a more advanced stage, it is a question of managing an influx of patients suffering from acute respiratory distress syndrome. In this case, the biology is then simpler and delocalized medical biology devices have proven their effectiveness. As a result, ICU clinicians can better manage the frequent comorbidities encountered in these regions: obesity, diabetes, chronic renal failure, cardiovascular diseases.
- Published
- 2022
- Full Text
- View/download PDF
21. [How to accredit bedside total hemoglobin measurement with the HemoCue ® point-of-care device?]
- Author
-
Augis V, Weinmann L, Castaing-Mouhica G, Terral C, Berthon N, Pujol S, and Beauvieux MC
- Subjects
- Hematologic Tests, Hospitals, University, Humans, Hemoglobins analysis, Point-of-Care Systems
- Abstract
HemoCue® point-of care devices are widely used in Bordeaux university hospital center to assess hemoglobin in critical situations, with 45 devices in 13 health units. Based on our experience, we here propose essential steps in order to prepare the accreditation file. We develop risks analysis, mandatory validation method check points, and caregiver professional training. Among the tasks, precise reference quality instructions i.e. instruction for use, maintenance and troubleshooting should be available. We also share reflections to offer solutions to encountered difficulties. The implemented quality management must rely on a solid and involved laboratory organization. A strong caregiver membership also appears to be the key to move forward.
- Published
- 2021
- Full Text
- View/download PDF
22. [Management of a global health crisis: first COVID-19 disease feedback from Overseas and French-speaking countries medical biologists].
- Author
-
Barguil Y, Chiaradia L, Sicard D, Duhin M, Sebat C, Abdi S, Alomar Y, Blondeel N, Bonnet C, Bouberi-Niava B, Bourgoin-Rousset E, Cavalier E, Cisse F, Combe P, de Guire V, Devaud F, De Wulf A, Agne FD, Dumas-Chastang E, Ecrabey YC, Grignon JC, Gruson D, Gueye PM, Hayette MP, Kabré E, Kandji PM, Kouakou HF, Legris-Allusson V, Lim S, Monde A, Monnet D, Forton GN, Outreville J, Padelli M, Sakandé J, Sall A, Subiros M, Tayeb N, Temmar A, Thiam S, Ting Wang H, Bérard AM, Piéroni L, Sapin V, and Beauvieux MC
- Subjects
- Adult, Africa epidemiology, Aged, Aged, 80 and over, Belgium epidemiology, Betacoronavirus physiology, Biomarkers analysis, Biomarkers blood, COVID-19, Cambodia epidemiology, Child, Contact Tracing methods, Contact Tracing statistics & numerical data, Coronavirus Infections transmission, Diagnosis, Differential, Female, France epidemiology, Hospitalization statistics & numerical data, Humans, Infant, Newborn, Islands epidemiology, Language, Laos epidemiology, Louisiana epidemiology, Male, Medical Laboratory Personnel organization & administration, Medical Laboratory Personnel statistics & numerical data, Middle Aged, Pandemics, Pneumonia, Viral transmission, Retrospective Studies, SARS-CoV-2, Surveys and Questionnaires, Survival Analysis, Travel Medicine methods, Travel Medicine statistics & numerical data, Travel-Related Illness, Tropical Climate, Tropical Medicine methods, Tropical Medicine organization & administration, Tropical Medicine statistics & numerical data, Vietnam epidemiology, Clinical Laboratory Services organization & administration, Clinical Laboratory Services statistics & numerical data, Coronavirus Infections diagnosis, Coronavirus Infections epidemiology, Coronavirus Infections therapy, Global Health statistics & numerical data, Pneumonia, Viral diagnosis, Pneumonia, Viral epidemiology, Pneumonia, Viral therapy, Travel Medicine organization & administration
- Abstract
The French society of clinical biology "Biochemical markers of COVID-19" has set up a working group with the primary aim of reviewing, analyzing and monitoring the evolution of biological prescriptions according to the patient's care path and to look for markers of progression and severity of the disease. This study covers all public and private sectors of medical biology located in metropolitan and overseas France and also extends to the French-speaking world. This article presents the testimonies and data obtained for the "Overseas and French-speaking countries" sub-working group made up of 45 volunteer correspondents, located in 20 regions of the world. In view of the delayed spread of the SARS-CoV-2 virus, the overseas regions and the French-speaking regions have benefited from feedback from the first territories confronted with COVID-19. Thus, the entry of the virus or its spread in epidemic form could be avoided, thanks to the rapid closure of borders. The overseas territories depend very strongly on air and/or sea links with the metropolis or with the neighboring continent. The isolation of these countries is responsible for reagent supply difficulties and has necessitated emergency orders and the establishment of stocks lasting several months, in order to avoid shortages and maintain adequate patient care. In addition, in countries located in tropical or intertropical zones, the diagnosis of COVID-19 is complicated by the presence of various zoonoses (dengue, Zika, malaria, leptospirosis, etc.).
- Published
- 2020
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.